PGHL

Procter & Gamble Health Share Price

₹5,287.05 -162.1 (-2.97%)

28 Dec, 2024 01:15

SIP TrendupStart SIP in PGHL

Start SIP

Performance

  • Low
  • ₹5,250
  • High
  • ₹5,460
  • 52 Week Low
  • ₹4,637
  • 52 Week High
  • ₹5,850
  • Open Price₹5,450
  • Previous Close₹5,449
  • Volume12,340

Investment Returns

  • Over 1 Month -0.22%
  • Over 3 Month + 0.69%
  • Over 6 Month + 5.61%
  • Over 1 Year + 6.78%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Invest Now

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.3
  • PEG Ratio
  • -6.8
  • Market Cap Cr
  • 8,776
  • P/B Ratio
  • 16.3
  • Average True Range
  • 159.88
  • EPS
  • 136.52
  • Dividend Yield
  • 3.8
  • MACD Signal
  • 54.68
  • RSI
  • 42.65
  • MFI
  • 38.14

Procter & Gamble Health Financials

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,287.05
-162.1 (-2.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹5,438.95
  • 50 Day
  • ₹5,371.22
  • 100 Day
  • ₹5,294.11
  • 200 Day
  • ₹5,196.99

Resistance and Support

5332.47 Pivot Speed
  • R3 5,625.43
  • R2 5,542.92
  • R1 5,414.98
  • S1 5,204.53
  • S2 5,122.02
  • S3 4,994.08

What's your outlook on Procter & Gamble Health?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide.

Procter & Gamble Health has an operating revenue of Rs. 1,159.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-04 Quarterly Results
2024-08-21 Audited Results & Final Dividend
2024-05-02 Quarterly Results
2024-02-06 Quarterly Results & Interim Dividend
2023-11-03 Quarterly Results
Date Purpose Remarks
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health F&O

Procter & Gamble Health Shareholding Pattern

51.82%
10.45%
4.09%
6.61%
0%
21.46%
5.57%

About Procter & Gamble Health

  • NSE Symbol
  • PGHL
  • BSE Symbol
  • 500126
  • Managing Director
  • Mr. Milind Thatte
  • ISIN
  • INE199A01012

Similar Stocks to Procter & Gamble Health

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,287 As on 28 December, 2024 | 01:01

The Market Cap of Procter & Gamble Health is ₹8776.2 Cr As on 28 December, 2024 | 01:01

The P/E ratio of Procter & Gamble Health is 40.3 As on 28 December, 2024 | 01:01

The PB ratio of Procter & Gamble Health is 16.3 As on 28 December, 2024 | 01:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23